Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
MLH1
REST API REST API
Homo sapiens
MLH1 is differentially expressed in 250 experiments: 91 organism parts: testis, blood, ... (89 more);, 160 disease states: normal, control, ... (158 more);, 80 cell types 362 cell lines 31 compound treatments and 66 other conditions.
Synonyms COCA2, HNPCC2, HNPCC, FCC2
Orthologs Q1RMN2_BOVIN (Bos taurus)   ENSCING00000002563 (Ciona intestinalis)   MLH1 (Saccharomyces cerevisiae)   Mlh1 (Mus musculus)   Mlh1 (Rattus norvegicus)   mlh1 (Danio rerio)   MLH1 (Gallus gallus)   Mlh1 (Drosophila melanogaster)   Q28IF0_XENTR (Xenopus laevis)   MLH1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term oogenesis, condensed nuclear chromosome, reciprocal meiotic recombination, double-strand break repair via nonhomologous end joining, protein binding, DNA repair, DNA damage response, signal transduction resulting in induction of apoptosis, response to toxin, meiosis, nuclear-transcribed mRNA poly(A) tail shortening, spindle midzone assembly involved in meiosis, ATPase activity, synaptonemal complex, male germ cell nucleus, spermatogenesis, response to hypoxia, single-stranded DNA binding, negative regulation of mitotic recombination, mismatched DNA binding, ATP binding, male meiosis chromosome segregation, cell cycle, meiotic metaphase I plate congression, nucleus, mismatch repair, resolution of meiotic recombination intermediates, response to drug, meiotic chromosome segregation, chromosome, response to DNA damage stimulus, male meiosis, condensed chromosome, guanine/thymine mispair binding, pachytene, somatic recombination of immunoglobulin gene segments, ATP catabolic process, MutLalpha complex, structure-specific DNA binding, somatic recombination of immunoglobulin genes involved in immune response, MutSalpha complex binding, somatic hypermutation of immunoglobulin genes, isotype switching, chiasma, MutLbeta complex, cellular response to organic cyclic compound
InterPro Term DNA_mismatch_repair_N, DNA_mismatch_repair_C, ATPase-like_ATP-bd
UniProt Accession A8W2I7, Q5GJ64, Q0ZAJ6, Q16335, Q59EG3, A5JTV0, A5JTV1, B7Z821, P40692, B4DI13, C9JZ54, C4PFY8, E7EUC9, E9PCU2, E9PE33, E9PEB4, E9PF25, F2Z298, F5H6L5, F5H745
Gene-Disease Assocation CAFE-AU-LAIT SPOTS, MULTIPLE, ENDOMETRIAL CANCER, MISMATCH REPAIR CANCER SYNDROME, MUIR-TORRE SYNDROME; MRTES, COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2
Search EB-eye ENSG00000076242
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-1577, E-MEXP-433, E-GEOD-3526, E-MTAB-62, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-19639, E-GEOD-18005, E-GEOD-19397, ... (34 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-3529, E-GEOD-20081, E-GEOD-19639
SW480
3
E-GEOD-18005, E-MEXP-1014, E-MTAB-37
DU145
2
E-GEOD-17482, E-GEOD-20089
HCC2157
2
E-MTAB-37, E-MTAB-62
K562
2
E-MTAB-37, E-GEOD-24147
MDA-MB-231
2
E-TABM-420, E-MTAB-62
356 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-19397, E-MEXP-750, E-GEOD-4219, E-GEOD-20677, ... (37 experiments)

Factor Value U/D Experiments
2
E-TABM-145, E-TABM-130
CD34+
2
E-AFMX-5, E-TABM-145
liver cancer
1
E-GEOD-21154
hematopoietic progenitor cells
1
E-MEXP-70
monolayer recovery
1
E-GEOD-4219
epidermoid
1
E-GEOD-19397
74 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-6872, E-MEXP-25, E-GEOD-15960, E-GEOD-2466, ... (47 experiments)

Factor Value U/D Experiments
prostate carcinoma
3
E-MEXP-2034, E-MTAB-62, E-GEOD-96
acute quadriplegic myopathy
2
E-MTAB-62, E-GEOD-3307
cervical carcinoma
2
E-MTAB-62, E-MEXP-1331
colon carcinoma
2
E-MTAB-62, E-MTAB-37
adenocarcinoma
1
2
E-MTAB-37, E-MTAB-62, E-MEXP-1331
metabolic syndrome
1
E-MTAB-62
154 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-6907, E-GEOD-3720, E-GEOD-5824, E-GEOD-5099, ... (21 experiments)

Factor Value U/D Experiments
none
3
4
E-GEOD-5824, E-GEOD-2649, E-MEXP-1601, E-GEOD-412, E-MEXP-1958, ... (7 experiments)
2-(3,4,5-trimethoxy-phenylamino)-pyrrolo[2,3-d]pyrimidines
1
E-GEOD-6932
vanadium pentoxide
1
E-GEOD-5339
interleukin-4 (Homo sapiens)
1
E-GEOD-5099
unknown
1
E-GEOD-7307
HMB-PP (phosphoantigen)
1
E-MEXP-1601
25 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

cd1a
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, E-GEOD-2034, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-MEXP-2359, E-GEOD-6236, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-89, E-GEOD-1323, E-GEOD-19743, E-TABM-147, E-GEOD-21138, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-4025, E-MEXP-1482, E-GEOD-17385, ... (8 experiments)

Genotype
studied in E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-GEOD-18005, E-TABM-601, ... (14 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (10 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-2466, E-GEOD-1926, E-MEXP-2069, ... (31 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12254, E-GEOD-980

Injury
studied in E-GEOD-19743

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-21750, E-GEOD-1460, E-GEOD-17636, E-GEOD-2487, E-GEOD-4600 ... (5 experiments)

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

RNAi
studied in E-MEXP-1509, E-GEOD-1676, E-GEOD-3697, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-MEXP-70, E-GEOD-17400

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-19815, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-89, E-GEOD-4290, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.478 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM